Compounds > 1-hydroxy-2,3,5-trimethoxyxanthene
Page last updated: 2024-12-11
1-hydroxy-2,3,5-trimethoxyxanthene
Description
1-hydroxy-2,3,5-trimethoxyxanthene, also known as **xanthotoxin**, is a naturally occurring furanocoumarin found in plants like parsley, celery, and figs. It's a potent photosensitizer, meaning it can absorb UV light and become reactive, causing damage to cells.
**Why is it important for research?**
* **Photosensitization and skin reactions:** Xanthotoxin's ability to induce skin reactions has been studied extensively. It's used in photochemotherapy (PUVA therapy) for treating psoriasis and vitiligo. This therapy involves exposing the skin to UV light after applying xanthotoxin, causing controlled skin cell death and promoting healthy skin growth.
* **DNA damage and phototoxicity:** Research indicates that xanthotoxin can damage DNA through its photoreactive properties. This has led to investigations into its potential role in skin cancer development, especially when combined with prolonged exposure to UV light.
* **Anti-inflammatory and antioxidant properties:** Besides its phototoxic effects, xanthotoxin has shown potential in reducing inflammation and acting as an antioxidant. Studies are exploring its potential use in treating inflammatory conditions like arthritis and inflammatory bowel disease.
* **Natural products research:** Xanthotoxin is a valuable subject in natural products chemistry research. Its complex structure and diverse biological activities make it an attractive molecule for studying the chemical and biological interactions of furanocoumarins.
**Important considerations:**
* Xanthotoxin is a potent photosensitizer, and exposure to sunlight after application can cause severe skin reactions.
* The use of xanthotoxin in photochemotherapy requires careful monitoring and dosage control to avoid adverse effects.
**In summary**, 1-hydroxy-2,3,5-trimethoxyxanthene (xanthotoxin) is an important molecule for research due to its unique phototoxic properties, potential applications in photochemotherapy and other therapeutic areas, and its significance in natural products chemistry. Further research is crucial to understand its complex biological effects and develop safe and effective applications.
1-hydroxy-2,3,5-trimethoxyxanthene: from Swertia tetrapetala Pall; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Flora | Rank | Flora Definition | Family | Family Definition |
Swertia | genus | A plant genus of the family GENTIANACEAE. It is a source of swertiapuniside and IRIDOID GLYCOSIDES.[MeSH] | Gentianaceae | A plant family of the order Gentianales, subclass Asteridae, class Magnoliopsida.[MeSH] |
Swertia tetrapetala | species | [no description available] | Gentianaceae | A plant family of the order Gentianales, subclass Asteridae, class Magnoliopsida.[MeSH] |
Cross-References
ID Source | ID |
PubMed CID | 5318372 |
SCHEMBL ID | 18240045 |
MeSH ID | M0106003 |
Synonyms (14)
Synonym |
xanthone, 1-hydroxy-2,3,5-trimethoxy- |
1-hydroxy-2,3,5-trimethoxyxanthen-9-one |
9h-xanthen-9-one, 1-hydroxy-2,3,5-trimethoxy- |
1-hydroxy-2,3,5-trimethoxyxanthene |
22804-49-5 |
1-htmx |
1-hydroxy-2,3,5-trimethoxyxanthone |
SCHEMBL18240045 |
AKOS025288392 |
FFVKXGZKJBHJMS-UHFFFAOYSA-N |
FS-8758 |
DTXSID80945485 |
1-hydroxy-2,3,5-trimethoxy-9h-xanthen-9-one |
1-hydroxy-2,3,5-trimethoxy-9h-xanthen-9-one;tovopyrifolin c 3,5-di-o-methyl ether |
Research
Studies (9)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 1 (11.11) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 3 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.48
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.48 (24.57) | Research Supply Index | 2.40 (2.92) | Research Growth Index | 4.88 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 10 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |